Kobo Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, revenue was INR 0.152 million compared to INR 0.166 million a year ago. Net loss was INR 25.69 million compared to INR 34.61 million a year ago. Basic loss per share from continuing operations was INR 1.08 compared to INR 1.45 a year ago.